62 related articles for article (PubMed ID: 7555375)
1. [Prevention and treatment of toxic and adverse effects of cisplatin].
Deng C; Huang R; Lian L; Song H
Zhonghua Fu Chan Ke Za Zhi; 1995 Jun; 30(6):376-9. PubMed ID: 7555375
[No Abstract] [Full Text] [Related]
2. [Tinnitus in the diagnosis and prognosis of ototoxicity].
Doménech J; Carulla M; Traserra J
Acta Otorrinolaringol Esp; 1990; 41(1):7-9. PubMed ID: 2337487
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-based chemotherapy: Add high-frequency audiometry in the regimen.
Arora R; Thakur JS; Azad RK; Mohindroo NK; Sharma DR; Seam RK
Indian J Cancer; 2009; 46(4):311-7. PubMed ID: 19749461
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hearing loss in children receiving cisplatin chemotherapy.
Freyer DR; Sung L; Reaman GH
J Clin Oncol; 2009 Jan; 27(2):317-8; author reply 318-9. PubMed ID: 19064953
[No Abstract] [Full Text] [Related]
5. cis-Diamminedichloroplatinum: a cytostatic with an ototoxic effect.
Hartwig S; Pettersson U; Stahle J
ORL J Otorhinolaryngol Relat Spec; 1983; 45(5):257-61. PubMed ID: 6684750
[TBL] [Abstract][Full Text] [Related]
6. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of cisplatin vestibulotoxicity and hearing loss.
Kobayashi H; Ohashi N; Watanabe Y; Mizukoshi K
ORL J Otorhinolaryngol Relat Spec; 1987; 49(2):67-72. PubMed ID: 3496573
[TBL] [Abstract][Full Text] [Related]
8. Neurochemistry of the peripheral and central auditory system after ototoxic drug exposure: implications for tinnitus.
Rybak LP
Int Tinnitus J; 2005; 11(1):23-30. PubMed ID: 16419684
[TBL] [Abstract][Full Text] [Related]
9. [Effects of high-doses cisplatin on the auditory function in children].
Stura M; Tarantino V; Perin GP; Dallorso S; Haupt R
Minerva Pediatr; 1986 Nov; 38(22):1069-74. PubMed ID: 3807851
[No Abstract] [Full Text] [Related]
10. Hearing loss in pediatric cancer survivors treated with cisplatin.
Knight K
Oncology (Williston Park); 2008 Apr; 22(4 Suppl Nurse Ed):35-7. PubMed ID: 19856560
[No Abstract] [Full Text] [Related]
11. Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.
Zuur CL; Simis YJ; Verkaik RS; Schornagel JH; Balm AJ; Dreschler WA; Rasch CR
Radiother Oncol; 2008 Oct; 89(1):38-43. PubMed ID: 18706728
[TBL] [Abstract][Full Text] [Related]
12. Ototoxicity in children treated for osteosarcoma.
Lewis MJ; DuBois SG; Fligor B; Li X; Goorin A; Grier HE
Pediatr Blood Cancer; 2009 Mar; 52(3):387-91. PubMed ID: 19061216
[TBL] [Abstract][Full Text] [Related]
13. Effects of cisplatin on olfactory function in cancer patients.
Yakirevitch A; Talmi YP; Baram Y; Weitzen R; Pfeffer MR
Br J Cancer; 2005 May; 92(9):1611-3. PubMed ID: 15827551
[TBL] [Abstract][Full Text] [Related]
14. Does ethanol have toxic effects on the kidney?
Cecchin E; De Marchi S
Nephrol Dial Transplant; 1994; 9(10):1522-3. PubMed ID: 7816276
[No Abstract] [Full Text] [Related]
15. Chronic cisplatin tubulopathy in humans and animals: clear-cut discrepant findings.
Kanaka C; Oetliker OH; Bianchetti MG
Nephron; 1991; 59(4):693. PubMed ID: 1766525
[No Abstract] [Full Text] [Related]
16. Recovery from cisplatin-induced ototoxicity: a case report and review.
Truong MT; Winzelberg J; Chang KW
Int J Pediatr Otorhinolaryngol; 2007 Oct; 71(10):1631-8. PubMed ID: 17706797
[TBL] [Abstract][Full Text] [Related]
17. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007
[TBL] [Abstract][Full Text] [Related]
18. [Development of sustained vasodilatory shock and permanent loss of hearing after severe lithium carbonate poisoning].
Plenge U; Møller AM
Ugeskr Laeger; 2008 Jan; 170(5):354. PubMed ID: 18252169
[TBL] [Abstract][Full Text] [Related]
19. Is the potential nephrotoxicity of drugs predictable? Experiences with a volunteer model.
Mondorf AW; Schoeppe W
Contrib Nephrol; 1984; 42():93-9. PubMed ID: 6152418
[No Abstract] [Full Text] [Related]
20. Efficacy of low-dose cisplatin-based chemo-irradiation in assessing hearing loss for locally advanced head and neck cancer.
Liao XB; Yan SX
Radiother Oncol; 2009 Feb; 90(2):282, author reply 282-3. PubMed ID: 19042049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
